Daniele Pastori | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Long-term cognitive function changes with non-vitamin K oral anticoagulants in older patients with atrial fibrillation. a multicenter cohort study	EUROPEAN JOURNAL OF CLINICAL INVESTIGATION	2025
Plasma Concentrations of Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation and Different Degrees of Obesity	CLINICAL PHARMACOKINETICS	2025
Statins as an Adjunctive Antithrombotic Agent in Thrombotic Antiphospholipid Syndrome: Mechanisms and Clinical Implications	CELLS	2025
Long-term left ventricular thrombosis resolution in patients receiving vitamin k antagonists: a multicenter observational study	INTERNAL AND EMERGENCY MEDICINE	2025
The severity of ischemic stroke and risk of all-cause mortality in patients with atrial fibrillation on different oral anticoagulant treatments admitted to the emergency department	JOURNAL OF THROMBOSIS AND THROMBOLYSIS	2025
Age related clinical efficacy of aspirin for primary cardiovascular prevention: a systematic-review and meta-analysis	THROMBOSIS AND HAEMOSTASIS	2025
Prognostic role of short physical performance battery in elderly hospitalized atrial fibrillation patients	INTERNAL AND EMERGENCY MEDICINE	2025
Risk of New-Onset Atrial Fibrillation in Opioid Users: A Systematic Review and Meta-Analysis on 24,006,367 Participants	DRUG SAFETY	2025
Lipid-Lowering Therapy and Cardiovascular Prevention in Elderly	DRUGS	2025
Quality of anticoagulation with vitamin K antagonists in Spain: A systematic review with meta-analysis of national registries	MEDICINA CLINICA	2025
Atrial Fibrillation, Heart Failure Phenotypes, and Mortality Risk in the Nationwide START Registry: A Propensity Score Matching Analysis	JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE	2025
Albumin Levels and Risk of Early Cardiovascular Complications After Ischemic Stroke: A Propensity-Matched Analysis of a Global Federated Health Network	STROKE	2024
Efficacy and Safety of Combination Therapy with Low-Dose Rivaroxaban in Patients with Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials	JOURNAL OF CLINICAL MEDICINE	2024
Endotoxemia and Platelets: 2 Players of Intrahepatic Microthrombosis in NAFLD	JACC. BASIC TO TRANSLATIONAL SCIENCE	2024
Prediction of new-onset atrial fibrillation with the C2HEST score in patients admitted with community-acquired pneumonia	INFECTION	2024
Lipid-based insulin-resistance markers predict cardiovascular events in metabolic dysfunction associated steatotic liver disease	CARDIOVASCULAR DIABETOLOGY	2024
Risk of adverse events in anticoagulated patients with atrial fibrillation and non-alcoholic fatty liver disease	THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM	2024
Midregional‐proAdrenomedullin as a prognostic tool in sepsis and septic shock: A systematic review and meta‐analysis	EUROPEAN JOURNAL OF CLINICAL INVESTIGATION	2024
Acute upper and lower gastrointestinal bleeding management in older people taking or not taking anticoagulants: a literature review	FRONTIERS IN MEDICINE	2024
Incidence of All-Cause, Cardiovascular, and Atrial Fibrillation-Related Hospitalizations	JACC. ADVANCES	2024

1
2
3
4
5
6
7
8
9
10
11
12
…
seguente ›
ultima »

ERC

LS4
LS4_10
LS7
LS7_10

Keywords

cardiovascular disease

anticoagulation

Novel oral anticoagulants

atrial fibrillation

atherosclerosis

NAFLD

NASH

antiphospholipid antibody syndrome

ischemic heart disease

cardiovascular risk

Thrombosis

Atherothrombosis

Progetti di Ricerca

Liver fibrosis and in-hospital outcomes in patients with acute coronary syndrome
Relationship between PCSK9 levels and major cardiovascular and cerebrovascular events (MACCE) in patients with non-alcoholic fatty liver disease (NAFLD): a prospective cohort study.